BioLife Solutions, Inc. Deferred Revenue Recognized
BioLife Solutions, Inc. (BLFS) reported Deferred Revenue Recognized of $26.00 thousand for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-06.
Financial Statements › Income Statement › Other Income
us-gaap:ContractWithCustomerLiabilityRevenueRecognized · last filed 2025-11-06
- BioLife Solutions, Inc. contract with customer, liability, revenue recognized for the quarter ending 2025-09-30 was $26.00K, a 74.00% decline year-over-year.
- BioLife Solutions, Inc. contract with customer, liability, revenue recognized for the quarter ending 2025-06-30 was $28.00K.
- BioLife Solutions, Inc. contract with customer, liability, revenue recognized for the quarter ending 2025-03-31 was $18.00K, a 95.50% decline year-over-year.
- BioLife Solutions, Inc. contract with customer, liability, revenue recognized for the quarter ending 2024-09-30 was $100.00K, a 0.00% change year-over-year.
- BioLife Solutions, Inc. contract with customer, liability, revenue recognized for fiscal 2024 was $39.00K, a 90.25% decline from fiscal 2023.
- BioLife Solutions, Inc. contract with customer, liability, revenue recognized for fiscal 2023 was $400.00K, a 21.72% decline from fiscal 2022.
- BioLife Solutions, Inc. contract with customer, liability, revenue recognized for fiscal 2022 was $511.00K, a 23.85% decline from fiscal 2021.
- BioLife Solutions, Inc. contract with customer, liability, revenue recognized for fiscal 2021 was $671.00K.
| Period end | Contract with Customer, Liability, Revenue Recognized 3 month | Contract with Customer, Liability, Revenue Recognized 6 month | Contract with Customer, Liability, Revenue Recognized 9 month | Contract with Customer, Liability, Revenue Recognized 12 month |
|---|---|---|---|---|
| 2025-09-30 | $26.00K 10-Q · filed 2025-11-06 | $100.00K 10-Q · filed 2025-11-06 | ||
| 2025-06-30 | $28.00K 10-Q · filed 2025-08-07 | $46.00K 10-Q · filed 2025-08-07 | ||
| 2025-03-31 | $18.00K 10-Q · filed 2025-05-08 | |||
| 2024-12-31 | $39.00K 10-K · filed 2025-03-03 | |||
| 2024-09-30 | $100.00K 10-Q · filed 2024-11-12 | $600.00K 10-Q · filed 2024-11-12 | ||
| 2024-06-30 | $0.00 10-Q · filed 2024-08-09 | $400.00K 10-Q · filed 2024-08-09 | ||
| 2024-03-31 | $400.00K 10-Q · filed 2024-05-10 | |||
| 2023-12-31 | $400.00K 10-K · filed 2024-02-29 | |||
| 2023-09-30 | $100.00K 10-Q · filed 2024-11-12 | $400.00K 10-Q · filed 2024-11-12 | ||
| 2023-06-30 | $0.00 10-Q · filed 2024-08-09 | $300.00K 10-Q · filed 2024-08-09 | ||
| 2023-03-31 | $200.00K 10-Q · filed 2024-05-10 | |||
| 2022-12-31 | $511.00K 10-K · filed 2023-03-31 | |||
| 2021-12-31 | $671.00K 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |